Underwriter Piper Jaffray helps fund clinical research and development
By Devika Patel
Knoxville, Tenn., March 18 – Anthera Pharmaceuticals, Inc. said it priced a $25 million public offering of stock with a $3.75 million greenshoe. The offering was announced on Tuesday.
The company will sell 5,555,556 common shares at $4.50 per share. The price per share reflects a 5.46% discount to the March 17 closing share price of $4.76.
Piper Jaffray & Co. is the underwriter.
Settlement is expected on March 23.
Proceeds will be used for clinical research, development and general corporate purposes.
Anthera, based in Hayward, Calif., is a biopharmaceutical company.
| Issuer: | Anthera Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $25 million
|
| Greenshoe: | $3.75 million
|
| Shares: | 5,555,556
|
| Price: | $4.50
|
| Warrants: | No
|
| Underwriter: | Piper Jaffray & Co.
|
| Announcement date: | March 17
|
| Pricing date: | March 18
|
| Settlement date: | March 23
|
| Stock symbol: | Nasdaq: ANTH
|
| Stock price: | $4.76 at close March 17
|
| Market capitalization: | $72.65 million
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
